Omnii research preview

Omnii for health is in early access

We're looking for phage therapy centers, clinicians, and hospitals treating patients with antibiotic-resistant bacterial infections.

We welcome clinical partners to reach out and provide bacterial isolates for screening. When promising candidates are identified and validated, we aim to work with treatment teams to manufacture patient-specific phage doses for potential use under appropriate regulatory pathways, including compassionate use.

← Back to research
Which Omnii are you interested in?

We’ll only use your details to contact you about Omnii early access. No spam. We also record basic signup attribution, such as the referring page and device type. Privacy policy